Niacin Coverage Agreed To By CMS In Reversal Of Earlier Decision
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS had originally determined niacin to be a vitamin and ineligible for coverage despite being a prescription product.
You may also be interested in...
Kos Bolsters Internal Sales Force To 1,000 Ahead Of New Launches
The company will not renew a co-promotion agreement with Takeda for Niaspan and Advicor.
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.